FDA Brief

Warning letters Devices

FDA warning letter to

BMC Medical Co., Ltd.

High riskIssued May 20Posted Jun 30Center for Devices and Radiological Health

BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.

What happened

FDA inspected 3B Medical, Inc. (d.b.a. React Health) in Dublin, Ohio, from December 1, 2025 through December 10, 2025, and determined that BMC Medical is the specification developer and 510(k) owner of imported ventilator devices. FDA found that BMC made significant design, material, and software changes to the cleared Luna APAP and marketed them as G3X APAP without a new 510(k); FDA also found BMC failed to report a firmware correction meant to prevent unexpected shutdown and loss of therapy.

What FDA found

  1. FDA says the G3X APAP was adulterated because BMC did not have an approved premarket approval application or an investigational device exemption for it.

    section 501(f)(1)(B), 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a); section 520(g), 21 U.S.C. § 360j(g)
  2. FDA says BMC made significant design, material, and software changes to the cleared Luna APAP and marketed the G3X APAP without submitting a new 510(k) premarket notification.

    section 502(o), 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k); 21 CFR 807.81(a)(3)
  3. FDA says BMC did not submit a Report of Correction or Removal within 10 working days for a firmware update from G3-2.00.76 to G3-2.00.77 intended to prevent unexpected shutdown and loss of therapy.

    section 502(t)(2), 21 U.S.C. § 352(t)(2); section 519, 21 U.S.C. § 360i; 21 CFR 806.10

What FDA wants

FDA tells BMC to cease activities that result in misbranding or adulteration and to respond in writing within 15 business days with the specific steps and corrective actions taken or planned to address the violations.

Who should pay attention

  • companies that import or distribute BMC/React Health sleep-apnea devices
  • specification developers and 510(k) owners of cleared medical devices
  • quality teams responsible for medical device correction and removal reports

This is a summary. Read the original letter on fda.gov.

BMC Medical Co., Ltd.'s FDA history

Recalls in the last 12 months

Aug 26 Class I BMC Medical Co., Ltd.
Device
BMC/REACTHEALTH Luna G3 APAP REF LG 3600
Retroactive reporting for 2024 rework conducted at the 3B/React Health warehouse

Full company page

Similar letters to other companies

  1. Next Medical Products Company, LLC

    FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.

    High risk
  2. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  3. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk
  4. O.N. Diagnostics, LLC

    FDA says O.N. Diagnostics sold changed VirtuOst VFA software without required clearance and had quality and reporting failures.

    High risk